Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-08

Clinical Trial Update: Subcutaneous Injection of Large Volumes of Tumescent Lidocaine and Epinephrine by Laypersons [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update exploring subcutaneous injections of large volumes of tumescent lidocaine and epinephrine by laypersons, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPINEPHRINE (EPINEPHRINE)
  • Lidocaine (Lidocaine)

Snippet

Sponsor: Jeffrey Alan Klein, MD | Conditions: Venomous Snakebites, Local Anesthesia | Phase 2, Phase 3 | Status: UNKNOWN